We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRSD
3076
Grandstand Limited Ordinary Shares
GRSD
$67M
| $166K | ﹤0.01% |
12,707
-163
| -1% | -$2.06K |
|
3077
Compañía de Cervecerías Unidas
CCU
$2.21B
| $166K | ﹤0.01% |
13,171
+420
| +3% | +$6.4K |
|
3078
XPeng
XPEV
$11.6B
| $165K | ﹤0.01% |
9,005
+710
| +9% | +$12K |
|
3079
PDS Biotechnology
PDSB
$43.4M
| $164K | ﹤0.01% |
32,514
+1,510
| +5% | +$8.27K |
|
3080
J. Jill
JILL
$283M
| $163K | ﹤0.01% |
5,522
+355
| +7% | +$8.32K |
|
3081
Mineralys Therapeutics
MLYS
$2.41B
| $163K | ﹤0.01% |
17,174
+2,279
| +15% | +$29.7K |
|
3082
BRC Inc
BRCC
$250M
| $162K | ﹤0.01% |
45,215
+466
| +1% | +$2.06K |
|
3083
Purple Innovation
PRPL
$41.7M
| $162K | ﹤0.01% |
3,782
-144
| -4% | -$8.98K |
|
3084
Stoke Therapeutics
STOK
$2.11B
| $162K | ﹤0.01% |
41,009
-1,166
| -3% | -$7.67K |
|
3085
Escalade
ESCA
$311M
| $161K | ﹤0.01% |
10,540
+545
| +5% | +$7.94K |
|
3086
Canadian Natural Resources
CNQ
$93.8B
| $161K | ﹤0.01% |
4,984
+70
| +1% | +$2.14K |
|
3087
Humacyte
HUMA
$194M
| $161K | ﹤0.01% |
54,945
+1,433
| +3% | +$4.74K |
|
3088
LCNB Corp
LCNB
$283M
| $161K | ﹤0.01% |
11,276
+468
| +4% | +$7.31K |
|
3089
Richardson Electronics
RELL
$304M
| $160K | ﹤0.01% |
14,631
+549
| +4% | +$7.08K |
|
3090
Rentokil
RTO
$12.2B
| $159K | ﹤0.01% |
4,304
+326
| +8% | +$12.5K |
|
3091
Princeton Bancorp
BPRN
$287M
| $159K | ﹤0.01% |
5,482
+277
| +5% | +$8.12K |
|
3092
Protalix BioTherapeutics
PLX
$198M
| $158K | ﹤0.01% |
95,403
+6,830
| +8% | +$12.3K |
|
3093
Harvard Bioscience
HBIO
$29.2M
| $158K | ﹤0.01% |
3,670
+214
| +6% | +$9.87K |
|
3094
Colliers International
CIGI
$5.19B
| $157K | ﹤0.01% |
1,648
| – | – |
|
3095
iShares MSCI Denmark ETF
EDEN
$206M
| $157K | ﹤0.01% |
1,561
| – | – |
|
|
FRGI
3096
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $157K | ﹤0.01% |
18,538
+959
| +5% | +$7.87K |
|
|
TIO
3097
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $156K | ﹤0.01% |
152,336
+6,589
| +5% | +$8.32K |
|
3098
Smartbird Inc
BIRD
$22.3M
| $156K | ﹤0.01% |
7,033
+152
| +2% | +$4.09K |
|
|
IGMS
3099
DELISTED
IGM Biosciences
IGMS
| $156K | ﹤0.01% |
18,696
-2,154
| -10% | -$18.3K |
|
|
ATE
3100
DELISTED
Advantest Corp
ATE
| $155K | ﹤0.01% |
1,387
+120
| +9% | +$13.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.